Target intelligence / Profile preview

Adipocyte plasma membrane lipid bilayer

Molecular classification
Lipid bilayer, Cellular structure
01

Overview

The adipocyte plasma membrane lipid bilayer is the fundamental structural boundary of the fat cell, composed of a complex arrangement of phospholipids, sphingolipids, and cholesterol (PubMed: 25650186). It serves as a critical platform for metabolic signaling, housing essential receptors and transporters such as the insulin receptor and GLUT4, which are vital for glucose homeostasis (NIH: PMC3518445). In pathological states such as obesity and type 2 diabetes, the lipid composition of this bilayer often shifts toward increased saturation, leading to decreased membrane fluidity and impaired signal transduction, a state closely linked to insulin resistance (PubMed: 22964371). While not a traditional protein target, the physical properties of the membrane are the focus of membrane-lipid therapy (melitherapy), which utilizes lipophilic compounds like BGP-15 to restore normal cellular function by altering membrane organization (Escribá et al., 2015). However, because it is a broad cellular structure rather than a discrete molecular entity, it is generally not classified as a specific therapeutic target in conventional drug discovery.

Other names
Adipocyte cell membraneFat cell plasma membraneAdipocyte surface membraneAdipocyte phospholipid bilayer
02

Mechanism of action

Modulation of membrane physical properties such as fluidity, thickness, and lipid raft organization to influence the activity of embedded signaling proteins like the insulin receptor.

03

Biological functions

CompartmentalizationSignal transduction platformRegulation of glucose transportLipid metabolism regulationCellular mechanosensing
04

Disease associations

ObesityType 2 diabetesInsulin resistanceMetabolic syndromeLipodystrophy
05

Safety considerations

Lack of molecular and tissue specificityPotential for systemic disruption of non-target cell membranesDifficulty in achieving targeted delivery to adipose tissuePotential for broad off-target toxicity
06

Interacting drugs

BGP-15

3 more in the full profile.

07

Biomarkers

Membrane fluidity indexPhospholipid fatty acid compositionOmega-3 to Omega-6 ratioCholesterol-to-phospholipid ratio

Beyond the preview

Go deeper on Adipocyte plasma membrane lipid bilayer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adipocyte plasma membrane lipid bilayer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call